全文获取类型
收费全文 | 1280篇 |
免费 | 91篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 36篇 |
妇产科学 | 25篇 |
基础医学 | 169篇 |
口腔科学 | 48篇 |
临床医学 | 109篇 |
内科学 | 260篇 |
皮肤病学 | 25篇 |
神经病学 | 71篇 |
特种医学 | 32篇 |
外科学 | 166篇 |
综合类 | 57篇 |
一般理论 | 2篇 |
预防医学 | 168篇 |
眼科学 | 43篇 |
药学 | 83篇 |
中国医学 | 15篇 |
肿瘤学 | 65篇 |
出版年
2024年 | 2篇 |
2023年 | 27篇 |
2022年 | 62篇 |
2021年 | 113篇 |
2020年 | 60篇 |
2019年 | 56篇 |
2018年 | 80篇 |
2017年 | 44篇 |
2016年 | 48篇 |
2015年 | 53篇 |
2014年 | 53篇 |
2013年 | 67篇 |
2012年 | 99篇 |
2011年 | 120篇 |
2010年 | 62篇 |
2009年 | 51篇 |
2008年 | 58篇 |
2007年 | 66篇 |
2006年 | 45篇 |
2005年 | 41篇 |
2004年 | 40篇 |
2003年 | 29篇 |
2002年 | 30篇 |
2001年 | 5篇 |
2000年 | 8篇 |
1999年 | 10篇 |
1998年 | 6篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1993年 | 4篇 |
1992年 | 4篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 5篇 |
1987年 | 4篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1974年 | 1篇 |
1947年 | 1篇 |
1945年 | 1篇 |
排序方式: 共有1381条查询结果,搜索用时 15 毫秒
31.
32.
Noor H. A. Suaini Evelyn Xiu-Ling Loo Rachel L. Peters Gaik Chin Yap Katrina J. Allen Hugo Van Bever David J. Martino Anne Eng Neo Goh Shyamali C. Dharmage Marjorelee T. Colega Mary Foong Fong Chong Anne-Louise Ponsonby Kok Hian Tan Mimi L. K. Tang Keith M. Godfrey Bee Wah Lee Lynette Pei-Chi Shek Jennifer J. Koplin Elizabeth Huiwen Tham 《Allergy》2021,76(10):3171-3182
33.
Noor Fatima Majeed Marta Braschi Amirfarzan Christoph Wald Jeremy R Wortman 《The British journal of radiology》2021,94(1123)
Objective:Spectral detector CT (SDCT) has many applications in advanced liver imaging. If appropriately utilized, this technology has the potential to improve image quality, provide new diagnostic information, and allow for decreased radiation dose. The purpose of this review is to familiarize radiologists with the uses of SDCT in liver imaging.Conclusion:SDCT has a variety of post-processing techniques, which can be used in advanced liver imaging and can significantly add value in clinical practice. 相似文献
34.
35.
Psychometric properties of the revised Malay version Medical Outcome Study Social Support Survey using confirmatory factor analysis among postpartum mothers 下载免费PDF全文
36.
The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults 总被引:5,自引:0,他引:5
Noor MA Parker RA O'Mara E Grasela DM Currie A Hodder SL Fiedorek FT Haas DW 《AIDS (London, England)》2004,18(16):2137-2144
BACKGROUND: Therapy with some HIV protease inhibitors (PI) contributes to insulin resistance and type 2 diabetes mellitus, by inhibition of insulin-sensitive glucose transporters. Atazanavir (ATV) is a new PI with substantially less in vitro effect on glucose transport than observed with other PI, including lopinavir (LPV) or ritonavir (RTV). METHODS: Randomized, double-blind, crossover study of the effect of 5 days of administering ATV, lopinavir/ritonavir (LPV/r) or placebo on insulin-stimulated glucose disposal in 30 healthy HIV-negative subjects. Each subject was studied on two of three possible treatments with a wash-out period between treatments. RESULTS: The mean insulin-stimulated glucose disposal (mg/min per kg body weight) per unit insulin (microU/ml) (M/I) was 9.88, 9.80 and 7.52 for placebo, ATV and LPV/r, respectively (SEM, 0.84 for all). There was no significant difference between ATV and placebo. The M/I for LPV/r was 23% lower than that for ATV (P = 0.010) and 24% lower than that for placebo (P = 0.008). The mean glycogen storage rates were 3.85, 4.00 and 2.54 mg/min per kg for placebo, ATV and LPV/r, respectively (SEM, 0.39 for all). There was no significant difference between ATV and placebo. The glycogen storage rate for LPV/r was 36% lower than ATV (P = 0.003) and 34% lower than placebo (P = 0.006). CONCLUSIONS: ATV given to healthy subjects for 5 days did not affect insulin sensitivity, while LPV/r induced insulin resistance. This observation is consistent with differential in vitro effects of these PI on glucose transport. Further data are needed to assess clinical implications for body composition. 相似文献
37.
Cytomorphology of palpable breast lesions: Diagnostic utility of FNAC in a developing country 下载免费PDF全文
38.
New recessive truncating mutation in LTBP3 in a family with oligodontia,short stature,and mitral valve prolapse 下载免费PDF全文
39.
40.
Nooraldaem Yousif Suddharsan Subbramaniyam Babu Thevan Mohammad Amin Leena Sulaibikh Nazar Bukamal Habib Tareif Sadananda Shivappa Haitham Amin Husam A. Noor 《Journal of the Saudi Heart Association》2020,32(3):434
BACKGROUNDTranscatheter aortic valve implantation (TAVI) is a minimally invasive procedure that is considered a good alternative to surgical aortic valve replacement (sAVR) in selected patients. Our aim is to determine the baseline, procedural characteristics and one-year clinical outcomes of our TAVI registry.METHODSThis study is a retrospective observational analysis of a prospectively designed cohort comprising 81 consecutive patients treated at Mohammed bin Khalifa Cardiac Centre (MKCC) who were enrolled in Bahrain TAVI registry from February 2014 to February 2019. The clinical endpoints were defined according to the updated Valve Academic Research Consortium-2 (VARC-2) consensus document.RESULTSOut of the 81 patients included in our study, there were 37 (45.7%) males. The mean age was 76.4 ± 8.9 years with a mean Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE II) of 4.1 ± 2.5 and a mean Society of Thoracic Surgery (STS) Risk Score of 4.2 ± 3.5. Evolute-R valve was used for 36 (44.4%) patients, Edward Sapien for 26 patients (32.1%), and Core valve for 19 patients (23.5%). At one year follow up, all-cause death was reported in three (3.7%) patients; none of them was cardiovascular mortality. As per VARC-II criteria, no cases fulfilled the criteria of valve dysfunction but TAVI-related complications (i.e., TAV-in-TAV deployment) were reported in four (4.9%) cases. One (1.2%) case of major bleeding was encountered but no patient experienced life-threatening bleeding. Major vascular complications were documented in two patients (2.5%) only. Significant Acute Kidney Injury (AKI) occurred in two (2.5%) patients, both classified as stage-2 but no one deteriorated to stage-3 or hemodialysis. Seven (8.6%) patients required permanent pacemakers, and all were implanted during the index admission for TAVI. One patient (1.2%) had stroke and all survivors completed one-year follow up.CONCLUSIONThe TAVI program in Bahrain is encouraging and corresponds to the finest international centers outcomes in terms of procedural success and complications rate. 相似文献